Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 151

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 151
---
 and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all the said attorney-in-fact and agent or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/  CRAIG COLLARD
     
    Chief Executive Officer and Director(Principal Executive Officer)
     
    February 27, 2025

    Craig Collard

    /s/  IRA DUARTE
     
    Executive Vice President, Chief Financial Officer(Principal Financial Officer)
     
    February 27, 2025

    Ira Duarte

    /s/  SHARMILA DISSANAIKE
     
    Director
     
    February 27, 2025

    Sharmila Dissanaike

    /s/ MICHAEL KASETA
     
    Director
     
    February 27, 2025

    Michael Kaseta

    /s/  CRAIG JOHNSON
     
    Director
     
    February 27, 2025

    Craig Johnson

    /s/ ADAM MORGAN
     
    Chairman of the Board of Directors
     
    February 27, 2025

    Adam Morgan

    /s/  SUSAN RODRIGUEZ
     
    Director
     
    February 27, 2025

    Susan Rodriguez

    /s/  CHRISTIAN WAAGE
     
    Director
     
    February 27, 2025

    Christian Waage

105